INFECTIOUS DISEASE

FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds

The Food and Drug Administration could authorize Covid-19 boosters from Pfizer Inc. PFE -2.96% and BioNTech SE BNTX 4.17% for use in 16- and 17-year olds as soon as next week as concerns rise over a new, possibly more transmissible variant, according to a person familiar with the planning.

LA begins enforcing strict mandate requiring proof of vax

Enforcement began Monday in Los Angeles for one of the strictest vaccine mandates in the country, a sweeping measure that requires proof of shots for everyone entering a wide variety of businesses from restaurants to theaters and gyms to nail and hair salons.

Moderna, Pfizer, J&J talk omicron response

As COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson & Johnson have outlined their respective strategies to tackle the new strain.